[1] Chan AT, Teo PM, Johnson PJ. Controversies in the management of locoregionally advanced nasopharyngeal carcinoma[J]. Curr Opin Oncol, 1998, 10(3):219-225. [2] Rabb-Traub N. Epstein-Barr virus in the pathogenesis of NPC[J]. Semin Cancer Biol, 2002, 12(6):431-441. [3] Ward MH, Pan WH, Cheng YJ, et al. Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan[J]. Int J Cancer, 2000, 86(5):603-609. [4] Jia WH, Feng BJ, Xu ZL, et al. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China[J]. Cancer, 2004, 101(2):363-369. [5] Zhang B, Nie X, Xiao B, et al. Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray[J]. Genes Chromosomes Cancer, 2003, 38(1):80-90. [6] 吴荫棠, 汪慧民, 杨小平, 等.鼻咽癌裸鼠移植瘤及其相应体外细胞株的建立与特性研究[J].癌症, 1995, 14(2):83-90. [7] 宋立兵, 鄢践, 简少文, 等.鼻咽癌细胞亚株不同成瘤与转移潜能的分子机制[J].癌症, 2002, 21(2):158-162. [8] Hopkins AL, Groom CR. The druggable genome[J]. Nat Rev Drug Discov, 2002, 1(9):727-730. [9] Wallin E, von Heijne G. Genome-wide analysis of integral membrane proteins from eubacterial, archaean and eukaryotic organisms[J]. Protein Sci, 1998, 7(4):1029-1038. [10] Simpson RJ, Connolly LM, Eddes JS. Proteomic analysis of the human colon carcinoma cell line(LIM 1215):Development of a membrane protein database[J]. Electrophoresis, 2000, 21(9):1707-1732. [11] Slanmon DJ, Leyland-Jones B, Shank S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that over-expresses HER2[J]. N Engl J Med, 2001, 344(11):783-792. [12] Oh P, Li Y, Yu J, et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumors for tissue-specific therapy[J]. Nature, 2004, 429(6992):629-635. [13] Cao R, Li X, Liang SP, et al. Integration of a two-phase partition method into proteomics research on rat liver plasma membrane proteins[J]. J Proteome Res, 2006, 5(3):634-642. [14] 陈主初, 梁宋平.肿瘤蛋白质组学[M].长沙:湖南科学技术出版社, 2002:81-82. [15] Li H, He Y, Ding G, et al. dbDEPC:a database of differentially expressed proteins in human cancers[J]. Nucleic Acids Res, 2010, 38(Database issue):D658-664. [16] Li F, Xiao ZQ, Zhang PF, et al. A reference map of human nasopharyngeal squamous carcinoma proteome[J]. Int J Oncol, 2007, 30(5):1077-1088. [17] 彭芳, 汤参娥, 李茂玉, 等.应用激光捕获显微切割技术纯化的鼻咽癌蛋白质表达谱的建立[J].中南大学学报:医学版, 2009, 34(6):481-486. [18] Cheng AL, Huang WG, Chen ZC, et al. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis[J]. Clin Cancer Res, 2008, 14(2):435-445. [19] Chen Y, Ouyang GL, Yi H, et al. Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis[J]. J Proteome Res, 2008, 7(12):5254-5262. [20] 向亚莉, 易红萃, 张鹏飞, 等. 鼻咽癌细胞系5-8F和6-10B的差异蛋白质组学研究[J].中南大学学报:医学版, 2007, 32(6):978-984. [21] Feng XP, Yi H, Li MY, et al. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics[J]. Cancer Res, 2010, 70(9):3450-3462. [22] Zhang LJ, Jia X, Liang SP, et al. Dataset of the plasma membrane proteome of nasopharyngeal carcinoma cell line HNE1 for uncovering protein function[J]. Acta Biochim Biophys Sin, 2008, 40(1):55-70. [23] Morré DJ, Morré DM. Preparation of mammalian plasma membranes by aqueous two-phase partition[J]. Biotechniques, 1989, 7(9):946-948, 950-954, 956-958. [24] Deblandre GA, Marinx OP, Evans SS, et al. Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth[J]. J Biol Chem, 1995, 270(40):23860-23866. [25] Yang G, Xu Y, Chen X, et al. IFITM1 plays an essential role in the antiproliferative action of interferon-gamma[J]. Oncogene, 2007, 26(4):594-603. [26] Conrads TP, Tocci GM, Hood BL, et al. CKAP4/p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients[J]. J Biol Chem, 2006, 281(49):37836-37843. [27] Zacharias DA, Mullen M, Planey SL. Antiproliferative factor-induced changes in phosphorylation and palmitoylation of cytoskeleton-associated protein-4 regulate its nuclear translocation and DNA binding[J]. Int J Cell Biol, 2012, 2012:150918. [28] Gerson KD, Shearstone JR, Maddula VS, et al. Integrin β4 regulates SPARC protein to promote invasion[J]. J Biol Chem, 287(13):9835-9844. [29] Sehgl BU, Debiase PJ, Matzno S, et al. Integrin beta 4 regulates migratory behavior of keratinocytes by determining laminin-332 organization[J]. J Biol Chem, 2006, 281(46):35487-35498. |